Aignostics Secures $34M Series B Funding to Advance AI Precision Medicine and U.S. Expansion

Publish Date:  December 18th, 2024

Berlin-based Aignostics has raised $34 million in Series B funding to expand its AI-driven precision medicine solutions, with key support from ATHOS, Mayo Clinic, and HTGF. The investment will drive U.S. expansion, new product development for biopharma, and advanced AI models for pathology. More Information here.